Mersana Therapeutics Inc. (MRSN) Fundamentals

Mersana Therapeutics Inc is a clinical stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is in a Phase 1 clinical trial in patients with tumors expressing NaPi2b, including ovarian cancer, NSCLC, and other cancers. In addition, multiple partners are using Mersana's platform to advance their ADC pipelines.
SHARE INFORMATION
Market Cap$ 488,836,142
Shares Outstanding96,991,298
Float96,211,341
Percent Float99.2%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 44,000
Latest Fiscal EPS$ -2.40
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions327
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months22,130,909
Institutional Holdings Percent116.0%
Institutional Sold Previous 3 Months18,721,198
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1,241,273
Insider Holdings Percent1.2
Insider Sold Previous 3 Months-
Insider Shares Owned1,147,184
TRADING INFO
52 Week High$ 14.80
52 Week Low$ 2.68
52 Week High Change$ -58.42
21 Day Moving Average$ 5.3343
21 Day Extended Moving Average$ 5.1088
50 Day Moving Average$ 4.503
50 Day Extended Moving Average$ 4.7456
200 Day Moving Average$ 5.1863
200 Day Extended Moving Average$ 5.9217
10 Day Average Volume1,106,414
20 Day Average Volume966,186
30 Day Average Volume1,181,749
50 Day Average Volume1,219,653
Alpha0.000628
Beta1.9131
Standard Deviation0.317779
R20.090666
7 Day Price Change$ -0.03
7 Day Percent Change-0.59%
21 Day Price Change$ -0.59
21 Day Percent Change-10.48%
30 Day Price Change$ 0.16
30 Day Percent Change3.28%
Month to Date Price Change$ -0.03
Month to Date Percent Change-0.59%
Quarter to Date Price Change$ 0.42
Quarter to Date Percent Change9.09%
180 Day Price Change$ 0.77
180 Day Percent Change18.03%
200 Day Price Change$ -1.24
200 Day Percent Change-19.75%
Year to Date Price Change$ -1.18
Year to Date Percent Change-18.97%

Mersana Therapeutics Inc. (MRSN) Key Ratios

PROFITABILITY
EBIT Margin-8,739.2%
EBITDA Margin-8,698.9%
Pre-Tax Profit Margin-91,365.5%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 2,058,000
Revenue Per Share$ 0.0212
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.50
Total Debt To Equity0.30
Int Coverage-95.20
Current Ratio4.30
Leverage Ratio1.80
Quick Ratio4.10
Long Term Debt To Capital0.20
VALUATION MEASURES
PE Ratio-2.00
Enterprise Value$ 296,452,141
Price to Sales237.5297
Price to Free Cash-5.60
PE High Last 5 Years-2.70
Price To Book3.50
Price To Cash Flow0.00
PE Low Last 5 Years-12.60
Price to Tangible Book3.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.40
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-74.18
Return on Equity-111.55
Return on Capital-92.14

Mersana Therapeutics Inc. (MRSN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOAnna Protopapas
Emplyoees78
Last AuditUQ
CIK0001442836
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address840 Memorial Drive
Cambridge, MA 2139
Websitehttp://www.mersana.com
Facsimile-
Telephone+1 617 498-0020
Emailchristina@sternir.com


Your Recent History
NASDAQ
MRSN
Mersana Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.